Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Ultomiris (Ravulizumab-cwvz) 1,100 Mg/11 Ml Sdv (CDM 63600814) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 5, 2026 , from http://ppman.hank.ai/transparency/procedure/63600814/by-state?code_type=CDM
“Ultomiris (Ravulizumab-cwvz) 1,100 Mg/11 Ml Sdv (CDM 63600814) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/63600814/by-state?code_type=CDM. Accessed
November 5, 2026 .
“Ultomiris (Ravulizumab-cwvz) 1,100 Mg/11 Ml Sdv (CDM 63600814) by State,” HANK Price Transparency ,
accessed November 5, 2026 ,
http://ppman.hank.ai/transparency/procedure/63600814/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
63600814 — Ultomiris (ravulizumab-cwvz) 1,100 Mg/11 Ml Sdv
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$57,340
National median
$47,428 – $72,328
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 63600814 (CDM), with interquartile range
State Median p25 p75
NC $57,340 $47,428 $72,328